Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Net Income towards Common Stockholders (2018 - 2025)

Dna X's Net Income towards Common Stockholders history spans 8 years, with the latest figure at $3.5 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at $3.5 million for Q4 2025, down 61.26% from a year ago — trailing twelve months through Dec 2025 was -$8.3 million (down 166.62% YoY), and the annual figure for FY2025 was -$12.7 million, up 58.71%.
  • Net Income towards Common Stockholders for Q4 2025 was $3.5 million at Dna X, up from -$4.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $8.9 million in Q4 2024 to a low of -$11.7 million in Q4 2021.
  • The 5-year median for Net Income towards Common Stockholders is -$2.7 million (2024), against an average of -$3.2 million.
  • Peak annual rise in Net Income towards Common Stockholders hit 1134.22% in 2024, while the deepest fall reached 1399.8% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at -$11.7 million in 2021, then soared by 91.11% to -$1.0 million in 2022, then increased by 17.27% to -$862000.0 in 2023, then surged by 1134.22% to $8.9 million in 2024, then plummeted by 61.26% to $3.5 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $3.5 million, -$4.8 million, and -$7.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.